title: 6-hydroxydopamine-induced nuclear factor-kappa B activation in PC12 cells.
abstract: The involvement of nuclear Factor-kappa B (NF-kappa B) transcription factor in PC12 cell death triggered by the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA) was investigated. Results show that oxidative stress generated by 6-OHDA activates NF-kappa B. When the NF-kappa B activation was inhibited by parthenolide, PC12 cell death induced by 6-OHDA was significantly increased, thus suggesting an involvement of this transcription factor in a protective mechanism against 6-OHDA toxicity. To further assess this hypothesis, we studied the involvement of NF-kappa B in the protective effect of two anti-apoptotic genes, bcl-2 and bfl-1. Although Bcl-2 and Bfl-1 expression normally protects PC12 cells from 6-OHDA, parthenolide strongly decreased the beneficial effects afforded by transgene expression. These results suggest: (1) that the transcription factor NF-kappa B is likely associated with the protection of catecholaminergic PC12 cells and (2) that the protective effects afforded by bcl-2 and bfl-1 expression may be dependent on NF-kappa activation.
authors.affiliation: Laboratoire de Neurophysiologie, Département de Neurosciences, ULB-Erasme, 808 route de Lennik, CP601, 1070 Bruxelles, Belgium. David.Blum@ulb.ac.be
authors.forename: D
authors.initials: D
authors.lastname: Blum
authors.forename: S
authors.initials: S
authors.lastname: Torch
authors.forename: M F
authors.initials: MF
authors.lastname: Nissou
authors.forename: J M
authors.initials: JM
authors.lastname: Verna
mesh_terms: D000818:Animals; D017209:Apoptosis; D004347:Drug Interactions; D015778:Minor Histocompatibility Antigens; D016328:NF-kappa B / Q000378:metabolism*; D009410:Nerve Degeneration / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D016627:Oxidopamine / Q000494:pharmacology*; D016716:PC12 Cells / Q000187:drug effects* / Q000378:metabolism; D010936:Plant Extracts / Q000494:pharmacology; D020011:Protective Agents / Q000494:pharmacology; D011506:Proteins / Q000494:pharmacology; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000494:pharmacology; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D012717:Sesquiterpenes / Q000494:pharmacology
chemical_list: C096816:BCL2-related protein A1; D015778:Minor Histocompatibility Antigens; D016328:NF-kappa B; D010936:Plant Extracts; D020011:Protective Agents; D011506:Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D017382:Reactive Oxygen Species; D012717:Sesquiterpenes; C002669:parthenolide; D016627:Oxidopamine